Citius Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 5/6
Citius Pharmaceuticals has a total shareholder equity of $86.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $97.1M and $10.8M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$17.91m |
| Equity | US$86.28m |
| Total liabilities | US$10.81m |
| Total assets | US$97.09m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 47N's short term assets ($28.0M) exceed its short term liabilities ($4.2M).
Long Term Liabilities: 47N's short term assets ($28.0M) exceed its long term liabilities ($6.7M).
Debt to Equity History and Analysis
Debt Level: 47N is debt free.
Reducing Debt: 47N has no debt compared to 5 years ago when its debt to equity ratio was 0.8%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 47N has sufficient cash runway for 7 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: Insufficient data to determine if 47N has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.